Literature DB >> 15786432

Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer.

Brent P Zabolotny1, Christian V Zalai, Sarkis H Meterissian.   

Abstract

Male breast cancer is an uncommon occurrence. Treatment of male breast cancer is typically extrapolated from data on the treatment of female breast cancer. Recently, aromatase inhibition has been proven as an effective therapy for female breast cancer, particularly in the setting of advanced cancers. The efficacy of aromatase inhibitors in males, however, has not been established. We report the successful treatment of a male with locally advanced breast cancer using the aromatase inhibitor letrozole. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15786432     DOI: 10.1002/jso.20233

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  11 in total

1.  Endocrine therapy for male breast cancer: rates of toxicity and adherence.

Authors:  H Visram; F Kanji; S F Dent
Journal:  Curr Oncol       Date:  2010-10       Impact factor: 3.677

2.  Sentinel lymph node biopsy in patients with male breast carcinoma: report of two cases.

Authors:  Masahiro Kitada; Keisuke Ozawa; Kazuhiro Sato; Satoshi Hayashi; Tadahiro Sasajima
Journal:  Surg Today       Date:  2011-05-28       Impact factor: 2.549

3.  Diagnosis and management of male breast cancer.

Authors:  Sophocles Lanitis; Alexandra J Rice; Alexander Vaughan; Paul Cathcart; George Filippakis; Ragheed Al Mufti; Dimitri J Hadjiminas
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

Review 4.  Indirect androgen doping by oestrogen blockade in sports.

Authors:  D J Handelsman
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

Review 5.  Male breast carcinoma: increased awareness needed.

Authors:  Jonathan White; Olive Kearins; David Dodwell; Kieran Horgan; Andrew M Hanby; Valerie Speirs
Journal:  Breast Cancer Res       Date:  2011-09-29       Impact factor: 6.466

6.  [Breast cancer in men: about 6 cases].

Authors:  Kamilia Laabadi; Sofia Jayi; Fatimazohra Fdili Alaoui; Hakima Bouguern; Hikmat Chaara; My Abdelilah Melhouf; Karim Ibn Majdoub Hassani; Said Ait Laalim; Hicham Anoun; Imane Toughrai; Khalid Mazaz
Journal:  Pan Afr Med J       Date:  2013-10-28

7.  Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report.

Authors:  Z Ballatore; M Pistelli; N Battelli; A Pagliacci; M De Lisa; R Berardi; S Cascinu
Journal:  BMC Res Notes       Date:  2016-11-28

8.  Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series.

Authors:  F Zagouri; T N Sergentanis; V Koutoulidis; C Sparber; G G Steger; P Dubsky; G C Zografos; T Psaltopoulou; M Gnant; M-A Dimopoulos; R Bartsch
Journal:  Br J Cancer       Date:  2013-05-30       Impact factor: 7.640

9.  Bilateral male breast cancer with male potential hypogonadism.

Authors:  Yukiko Hirose; Mitsunori Sasa; Yoshimi Bando; Toshiyuki Hirose; Tadaoki Morimoto; Yasushi Kurokawa; Taeko Nagao; Akira Tangoku
Journal:  World J Surg Oncol       Date:  2007-06-02       Impact factor: 2.754

10.  Breast conserving surgery with preservation of the nipple-areola complex as a feasible and safe approach in male breast cancer: a case report.

Authors:  Sophocles Lanitis; George Filippakis; Ragheed Al Mufti; Dimitri J Hadjiminas
Journal:  J Med Case Rep       Date:  2008-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.